Altimmune, Inc. (ALT)
1.535
-0.02
(-1.60%)
USD |
NASDAQ |
Nov 17, 16:00
1.55
+0.02
(+0.98%)
After-Hours: 20:00
Altimmune Price : 1.535 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 1.64 | 1.67 | 1.50 | 1.56 | 6.088M |
| Nov 13, 2026 | 1.625 | 1.67 | 1.58 | 1.645 | 3.534M |
| Nov 12, 2026 | 1.90 | 1.90 | 1.60 | 1.61 | 12.45M |
| Nov 11, 2026 | 1.95 | 1.985 | 1.90 | 1.93 | 2.940M |
| Nov 10, 2026 | 2.12 | 2.13 | 1.90 | 1.94 | 3.995M |
| Nov 09, 2026 | 2.09 | 2.21 | 2.05 | 2.12 | 4.367M |
| Nov 06, 2026 | 1.97 | 2.10 | 1.95 | 2.08 | 2.774M |
| Nov 05, 2026 | 2.12 | 2.127 | 1.91 | 1.97 | 4.206M |
| Nov 04, 2026 | 2.10 | 2.15 | 2.02 | 2.12 | 3.484M |
| Nov 03, 2026 | 2.03 | 2.08 | 2.03 | 2.04 | 2.398M |
| Nov 02, 2026 | 2.07 | 2.106 | 2.01 | 2.02 | 2.741M |
| Oct 30, 2026 | 2.135 | 2.135 | 1.99 | 2.04 | 3.520M |
| Oct 29, 2026 | 2.105 | 2.18 | 2.10 | 2.14 | 2.684M |
| Oct 28, 2026 | 2.03 | 2.10 | 1.995 | 2.10 | 4.332M |
| Oct 27, 2026 | 2.07 | 2.15 | 2.01 | 2.04 | 4.968M |
| Oct 26, 2026 | 2.13 | 2.15 | 2.02 | 2.05 | 3.499M |
| Oct 23, 2026 | 2.16 | 2.20 | 2.06 | 2.12 | 2.600M |
| Oct 22, 2026 | 2.20 | 2.245 | 2.15 | 2.17 | 3.094M |
| Oct 21, 2026 | 2.31 | 2.35 | 2.19 | 2.23 | 4.502M |
| Oct 20, 2026 | 2.22 | 2.32 | 2.20 | 2.30 | 2.306M |
| Oct 19, 2026 | 2.22 | 2.26 | 2.18 | 2.23 | 2.611M |
| Oct 16, 2026 | 2.365 | 2.369 | 2.17 | 2.20 | 4.243M |
| Oct 15, 2026 | 2.31 | 2.38 | 2.29 | 2.36 | 3.354M |
| Oct 14, 2026 | 2.40 | 2.41 | 2.29 | 2.31 | 5.627M |
| Oct 13, 2026 | 2.56 | 2.56 | 2.43 | 2.43 | 3.718M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Imunon, Inc. | 0.6166 |
| Taysha Gene Therapies, Inc. | 4.005 |
| Agenus, Inc. | 6.225 |
| Amgen, Inc. | 457.91 |
| Anika Therapeutics, Inc. | 12.89 |
Price Related Metrics
| PS Ratio | 9088.86 |
| Price to Book Value | 0.6732 |
| Earnings Yield | -47.58% |
| Market Cap | 298.62M |